We have previously shown that loss of key base excision repair (BER) repair proteins such as XRCC1 [24] or polymerase β [25] in DCIS are also linked with aggressive clinicopathological features and survival. This evidence concerns the gene XRCC1 and ductal breast carcinoma in situ.